Experimental Hematology & Oncology

Published by BMC

Open access · CC BY-NC-ND · In DOAJ · United Kingdom · CAR-T cell therapy research

Journal at a glance

ISSN

2162-3619

Publisher

BMC

Country

United Kingdom

Language

en

License

CC BY-NC-ND

Also known as: Exp Hematol Oncol (Abbreviation), Experimental hematology and oncology (Alternate title)

Indexing

• Web of Science (SCIE): Indexed
• DOAJ: Active
• Scopus: Indexed
• Pubmed: Active

Metrics

Subjects

• CAR-T cell therapy research
• Acute Myeloid Leukemia Research
• Cancer Immunotherapy and Biomarkers
• Lymphoma Diagnosis and Treatment
• Immune Cell Function and Interaction
• Immunotherapy and Immune Responses
• Immune cells in cancer
• Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
• Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
• Internal medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programs (2026)
• Emerging agents and regimens for myeloproliferative neoplasms: updates from ASH 2025 Annual Meeting (2026)
• Arsenic trioxide promotes a glue‑like interaction to drive STUB1-mediated NPM-ALK degradation in ALK+ ALCL (2026)
• Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting (2026)
• Optimizing the timing of JAK1 inhibition preserves the anti-tumor efficacy of radioimmunotherapy in lung cancer by preventing T cell exhaustion (2026)

Similar journals

• Journal for ImmunoTherapy of Cancer — United Kingdom · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same country, Same language
• JCI Insight — United States · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same language
• ImmunoTargets and Therapy — New Zealand · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same language
• Immuno — Switzerland · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same language
• Nature Cancer — United States · — · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• Journal of Translational Medicine — United Kingdom · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total, Same country, Same language

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate), Scopus · Last verified 2026-09-05

Journal homepage · Author guidelines